Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2

Conditions

Immunoglobulin Light-chain Amyloidosis 2Paraproteinemias 1Multiple Myeloma 1Monoclonal Gammopathy of Undetermined Significance 1Amyloidosis 1

Interventions

Standard of Care 177Blood Specimen Collection 138Exercise 123Educational Status 114Methods 109Interviews as Topic 106Practice Guidelines as Topic 105Surveys and Questionnaires 104Early Intervention, Educational 93Magnetic Resonance Spectroscopy 80Specimen Handling 78Radiosurgery 68Radiotherapy 56Palliative Care 48Biopsy 40Patient Navigation 37Control Groups 34Resistance Training 32Drug Therapy 32Therapeutics 31Surgical Procedures, Operative 31Diet Therapy 30Counseling 29Behavior Therapy 29Acupuncture Therapy 25Proton Therapy 24Nutrition Assessment 24Exercise Test 24Magnetic Resonance Imaging 23Radiation 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × 4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene × 1 year × Clear all
NCT07624760 2026-06-03

MGUS-PET

University of Zurich

Phase NA Not yet recruiting
50 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Paraproteinemias

NCT04392960 2026-04-16

Novel Imaging Tools in Newly-diagnosed Patients With Cardiac AL Amyloidosis

Fondazione IRCCS Policlinico San Matteo di Pavia

Phase NA Completed
30 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡